Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global CTCPT Market Portraiture
2.2. Global CTCPT Market, by Technology, 2017 (US$ Mn)
2.3. Global CTCPT Market, by Application, 2017 (US$ Mn)
2.4. Global CTCPT Market, by Geography, 2017 (US$ Mn)
Chapter 3. Circulating Tumor Cells Prognostic Technologies (CTCPT) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global CTCPT Market, by Key Players, 2017
Chapter 4. Global Circulating Tumor Cells Prognostic Technologies (CTCPT) Market, by Technology
4.1. Overview
4.2. Tumor Cells Enrichment
4.2.1. Centrifugation
4.2.2. Filtration
4.2.3. Immunological and Immunomagnetic Methods
4.3. Tumor Cells Detection
4.3.1. Molecular Methods
4.3.2. Optical Methods
Chapter 5. Global Circulating Tumor Cells Prognostic Technologies (CTCPT) Market, by Application
5.1. Overview
5.2. Breast Cancer
5.3. Prostate Cancer
5.4. Colorectal Cancer
5.5. Others (Pancreatic, Ovarian Cancer etc.)
Chapter 6. Global Circulating Tumor Cells Prognostic Technologies (CTCPT) Market, by Geography
6.1. Overview
6.2. North America CTCPT Market Analysis, 2016 – 2026
6.2.1. North America CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
6.2.2. North America CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America CTCPT Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe CTCPT Market Analysis, 2016 – 2026
6.3.1. Europe CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
6.3.2. Europe CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe CTCPT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific CTCPT Market Analysis, 2016 – 2026
6.4.1. Asia Pacific CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific CTCPT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America CTCPT Market Analysis, 2016 – 2026
6.5.1. Latin America CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
6.5.2. Latin America CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America CTCPT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa CTCPT Market Analysis, 2016 – 2026
6.6.1. MEA CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
6.6.2. MEA CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA CTCPT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. AdnaGen GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Technology Portfolio
7.1.4. News Coverage
7.2. Advanced Cell Diagnostics, Inc.
7.3. AVIVA Biosciences Corporation
7.4. Celula, Inc.
7.5. Epic Sciences, Inc.
7.6. Fluxion Biosciences, Inc.
7.7. Rarecells USA, Inc.
7.8. Vitatex, Inc.
7.9. Veridex, LLC.
7.10. Silicon Biosystems, S.p.A.
List of Figures
FIG. 1 Circulating Tumor Cells Prognostic Technologies (CTCPT) Market: Research Methodology
FIG. 2 CTCPT Market Segmentation
FIG. 3 Global CTCPT Market, by Technology, 2017 (US$ Mn)
FIG. 4 Global CTCPT Market, by Application, 2017 (US$ Mn)
FIG. 5 Global CTCPT Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global CTCPT Market, by Key Players, 2017
FIG. 8 Global Centrifugation Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
FIG. 9 Global Filtration Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
FIG. 10 Global Immunological and Immunomagnetic Methods Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
FIG. 11 Global Molecular Methods Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
FIG. 12 Global Optical Methods Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
FIG. 13 Global Breast Cancer Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
FIG. 14 Global Prostate Cancer Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
FIG. 15 Global Colorectal Cancer Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
FIG. 16 Global Other Applications Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
FIG. 17 U.S. CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 18 Canada CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 19 U.K. CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 20 Germany CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Europe CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 22 China CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 23 Japan CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 24 Rest of Asia Pacific CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 25 Brazil CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 26 Mexico CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of Latin America CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 28 GCC CTCPT Market, 2016 – 2026 (US$ Mn)
FIG. 29 Rest of MEA CTCPT Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 Global Circulating Tumor Cells Prognostic Technologies (CTCPT) Market Portraiture
TABLE 2 Global CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 3 Global Tumor Cells Enrichment Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
TABLE 4 Global Tumor Cells Detection Market for Circulating Tumor Cells Prognostic Technologies, 2016 – 2026 (US$ Mn)
TABLE 5 Global CTCPT Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 6 Global CTCPT Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 7 North America CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 8 North America CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 9 North America CTCPT Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 11 Europe CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 12 Europe CTCPT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific CTCPT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 17 Latin America CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America CTCPT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa CTCPT Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 20 Middle East and Africa CTCPT Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 21 Middle East and Africa CTCPT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 22 AdnaGen GmbH: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)
TABLE 23 Advanced Cell Diagnostics, Inc.: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)
TABLE 24 AVIVA Biosciences Corporation: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)
TABLE 25 Celula, Inc.: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)
TABLE 26 Epic Sciences, Inc.: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)
TABLE 27 Fluxion Biosciences, Inc.: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)
TABLE 28 Rarecells USA, Inc.: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)
TABLE 29 Vitatex, Inc.: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)
TABLE 30 Veridex, LLC: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)
TABLE 31 Silicon Biosystems, S.p.A.: Company Snapshot (Business Description; Financial Information; Technology Portfolio; Key Developments)